Respiratory disease testing market involves testing for various respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), lung cancer, pneumonia, tuberculosis, and sleep apnea. The common types of respiratory disease testing include laboratory tests, imaging tests, and pulmonary function tests. Laboratory tests include complete blood count, arterial blood gas, sputum culture etc. Imaging tests comprise chest X-ray, CT scan, MRI etc. Pulmonary function tests are performed to measure lung function parameters like lung volumes, diffusion capacity and airflow limitation.

The global Respiratory Disease Testing Market is estimated to be valued at US$ 3,232 Mn in 2023 and is expected to exhibit a CAGR of 4.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.


Market Dynamics:

Increased adoption of mobile-based respiratory disease testing applications is anticipated to drive the market growth during the forecast period. Mobile based applications provide an easy way to monitor lung functions at home. For instance, companies like Vitalograph offer mobile compatible spirometers and lung function testing apps. Increased research activities focusing on development of advanced diagnostic tests is another major factor boosting the market growth. Growing geriatric population worldwide which is more prone to respiratory diseases is fueling the demand for respiratory disease testing. Furthermore, rising prevalence of smoking and air pollution are leading to increased incidence of respiratory diseases thereby propelling the market growth.

Segment Analysis

The respiratory disease testing market can be segmented based on tests, diseases, end-users and regions. Based on test types, pulmonary function tests are dominating the market as it is considered highly effective for tests related to lung capacity and airway disease diagnosis. Pulmonary function tests measure how much air a person can inhale and exhale with time and helps understand the functioning of lungs better.

PEST Analysis

Political: Governments across countries are raising awareness about respiratory diseases through campaigns and allocating higher healthcare budgets which is positively impacting the market growth.

Economic: Rise in per capita healthcare expenditure is enabling more people to opt for respiratory disease diagnosis tests. Growing middle class population with increased disposable incomes is also supporting market growth.

Social: Growing pollution levels and changing lifestyle factors resulting into increased smoking is leading to higher prevalence of respiratory diseases. This is increasing the demand for associated tests in the market.

Technological: Developments in medical imaging technologies like CT scans and introduction of portable diagnostic devices are enabling easy and affordable respiratory disease diagnosis. This is positively influencing the market.

Key Takeaways

The global Respiratory Disease Testing Market Share  is expected to witness high growth, exhibiting CAGR of 4.0% over the forecast period, due to increasing pollution levels globally.

The Asia Pacific region is projected to witness fastest growth in the respiratory disease testing market due to rising health awareness, growing geriatric population and escalating pollution in counties like China and India.

Regionally, North America dominated the market and is expected to continue its dominance during the forecast period attributed to growing prevalence of respiratory diseases like asthma and presence of major players in the region.

Key players operating in the respiratory disease testing market are CareFusion Corporation, Carestream Health, Inc., COSMED, Futuremed America, Inc., GE Healthcare, MGC Diagnostics Corporation, ndd Medical Technologies, Inc., Nihon Kohden Corporation, Perkin Elmer, Inc., FUJIFILM Healthcare Corporation, Philips Healthcare,Roche Healthcare, Beckton  and Company, Koninklijke Philips N.V. , ResMed Inc., Medtronic, Abbott Diagnostics, and Quest Diagnostics.

Key players like Philips Healthcare are focusing on strengthening their market position through new product launches. For instance, in 2019, Philips Healthcare launched new digital diagnostic solutions for respiratory conditions.

For more insights, Read-

https://www.pressreleasebulletin.com/respiratory-disease-testing-market-trends-share-analysis/